Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M52.5Revenue (TTM) $M216Net Margin (%)-56.9Altman Z-Score-1.8
Enterprise Value $M270EPS (TTM) $-4.2Operating Margin %-43.9Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.4Pre-tax Margin (%)-56.1Higher ROA y-yY
Price/Book1.010-y EBITDA Growth Rate %--Quick Ratio0.8Cash flow > EarningsY
Price/Sales0.25-y EBITDA Growth Rate %7.1Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-28.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-99.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.5ROIC % (ttm)-31.0Gross Margin Increase y-yN

Gurus Latest Trades with AEGR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEGRJohn Paulson 2016-03-31 Sold Out $3.48 - $10.1
($6.27)
$ 1.85-70%Sold Out0
AEGRJohn Paulson 2015-12-31 Buy $8.95 - $16.36
($11.97)
$ 1.85-85%New holding26,400
AEGRMichael Price 2014-12-31 Sold Out -1%$19.66 - $35.02
($25.02)
$ 1.85-93%Sold Out0
AEGRGeorge Soros 2014-12-31 Sold Out -0.01%$19.66 - $35.02
($25.02)
$ 1.85-93%Sold Out0
AEGRJoel Greenblatt 2014-12-31 Sold Out $19.66 - $35.02
($25.02)
$ 1.85-93%Sold Out0
AEGRGeorge Soros 2014-09-30 Buy 0.01%$26.93 - $35.65
($30.96)
$ 1.85-94%New holding25,000
AEGRJoel Greenblatt 2014-09-30 Buy $26.93 - $35.65
($30.96)
$ 1.85-94%New holding10,964
AEGRMichael Price 2014-03-31 Buy 1.1%$43.65 - $73.75
($59.26)
$ 1.85-97%New holding200,000
AEGRGeorge Soros 2012-06-30 Sold Out -0.01%$11.76 - $16.96
($14.02)
$ 1.85-87%Sold Out0
AEGRGeorge Soros 2011-06-30 Buy 0.01%$15.29 - $21.85
($17.62)
$ 1.85-90%New holding37,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEGR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AEGR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Broadfin Healthcare Master Fun10% Owner 2015-11-11Buy40,100$10.96-83.12view
Fitzpatrick Mark J.CFO 2014-08-19Buy1,150$30.64-93.96view
Beer Marc DCEO 2014-07-31Buy10,000$33.65-94.5view
Beer Marc DCEO 2014-06-03Buy10,000$30.12-93.86view
Beer Marc DCEO 2014-05-27Buy10,000$31.59-94.14view
Beer Marc DCEO 2014-05-20Buy10,000$30.53-93.94view
Beer Marc DCEO 2014-05-08Buy30,000$35.31-94.76view
VANLENT ANNEDirector 2014-05-08Buy4,000$33.78-94.52view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-04-30Sell2,250$43.55-95.75view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-03-31Sell2,250$46.2-96view

Quarterly/Annual Reports about AEGR:

News about AEGR:

Articles On GuruFocus.com
Stocks Reach 5-Year Lows Apr 11 2016 
Stocks Reach 5-year Lows Apr 04 2016 
Stocks Fall to 5-Year Lows Mar 28 2016 
Gilead Sciences Releases Impressive Results for Hepatitis C Drug Nov 12 2014 
Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
Weekly CEO Buys Highlight: GEO, TRUE, BANC, AEGR, CLMS Jun 02 2014 
Three CEOs Reporting Large Insider Buys May 22 2014 
Four CEOs Reporting Large Insider Buys May 09 2014 
100 Stocks at All-Time Highs | 60 Dividend Stocks Below the Results Feb 19 2013 
My 3 Favorite Dividend Stocks at All-Time-Highs | Stock List Dec 27 2012 

More From Other Websites
7 Stocks Under $10 to Trade for Big Profits May 27 2016
AEGERION PHARMACEUTICALS, INC. Financials May 24 2016
Robbins Arroyo LLP Is Investigating the Officers and Directors of Aegerion Pharmaceuticals, Inc.... May 19 2016
ETF’s with exposure to Aegerion Pharmaceuticals, Inc. : May 19, 2016 May 19 2016
Aegerion Pharmaceuticals, Inc. :AEGR-US: Earnings Analysis: Q1, 2016 By the Numbers May 18 2016
IBB’s Holdings Surge on Positive Market Sentiment May 17 2016
​Aegerion on the hunt for rare drug makers in need of sales help May 17 2016
Aegerion (AEGR) Misses Q1 Earnings Estimates, Cuts View May 17 2016
Edited Transcript of AEGR earnings conference call or presentation 16-May-16 9:00pm GMT May 16 2016
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 16 2016
AEGERION PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 16 2016
Aegerion Pharmaceuticals Announces First Quarter 2016 Financial Results May 16 2016
Aegerion reports 1Q loss May 16 2016
Aegerion reports 1Q loss May 16 2016
Aegerion Pharmaceuticals Announces First Quarter 2016 Financial Results May 16 2016
Q1 2016 Aegerion Pharmaceuticals Inc Earnings Release - After Market Close May 16 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation into... May 13 2016
Faruqi & Faruqi, LLP is Investigating Aegerion Pharmaceuticals, Inc. (AEGR) on Behalf of its... May 13 2016
Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Hold Aegerion Pharmaceuticals,... May 13 2016
Aegerion Enters into Settlement Agreement with DoJ and SEC May 13 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)